Gantenerumab for treating early Alzheimer's disease [TSID10668]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Pridopidine for treating Huntington's disease [ID6525]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC